The Journal of Surgical Oncology publishes research in the field of surgical and clinical oncology and broadly related surgical sciences, including experimental and laboratory studies on cancer research & treatment, pathology, radiology, multimodality treatment and more. We encourage participation from leading surgeons and cancer specialists around the world. Guest Editors from our Editorial Board oversee multiple special Seminars issues each year, which include multifaceted Reviews on a particular topic in surgical oncology.


It has come to our attention that an entity called "Science Repository" has launched an open access journal under the name "Journal of Surgical Oncology" at the following URL: Please note that this publication has no connection with the Wiley-owned journal (ISSN 1096-9098), no ISSN, no content and no impact factor at present.

Nevertheless, Science Repository is actively targeting Wiley contributors to submit material to their journal upon payment of a fee or in some cases with a fee waiver. Authors and contributors should be careful to submit articles only to the Wiley Journal of Surgical Oncology at Authors who submit manuscripts to sites outside the official Wiley submission workflow are likely to lose both their money and their manuscript, which can then not be published in the official Wiley journal.

Please also refer to the Think Check Submit site at for additional information on submitting articles to an appropriate journal for your research.

The editors and publishers at Wiley would also be interested to have you forward examples of spam if you have been targeted by Science Repository.


Journal of Surgical Oncology Seminar Series Collection

Click here for a full of JSO's Seminar Issues from the past few years.

Our latest Seminar Issue:

Volume 126, Issue 1

Proceedings of the 15th Brazilian Congress of Surgical Oncology, Salvador-Bahia Brazil November 17-20, 2021
July 2022

Issue Edited by: Flavio G. RochaRodrigo Nascimento PinheiroAlexandre Ferreira Oliveira

On the Cover

Skip slideshowmore >


free access

Issue Information

  •  1401-1405
  •  24 June 2024

Adjuvant chemotherapy versus preoperative chemotherapy for gastric cancer treated with curative‐intent resection: A propensity score‐matched analysis

  •  21 June 2024


Multimodal therapy (MMT) with surgery plus perioperative (PCMT) or adjuvant chemotherapy (ACMT) have been shown to improve survival when compared with surgery alone in advanced gastric cancer (GC)

Both methods of CMT delivery are widely used. However, the moment of administering chemotherapy for GC is still a matter of debate.

More articles

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

More articles

Latest news

Recent issues